These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 15761755)
1. Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure. Watz R; Ekstrand AB; Engelbrektson V; Beermann B Eur J Clin Pharmacol; 2005 May; 61(3):209-14. PubMed ID: 15761755 [TBL] [Abstract][Full Text] [Related]
2. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons. Aronow WS J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528 [TBL] [Abstract][Full Text] [Related]
3. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey. Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M; Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacologic treatment of heart failure in the elderly]. Erdmann E Dtsch Med Wochenschr; 2013 Apr; 138(14):700-2. PubMed ID: 23533033 [No Abstract] [Full Text] [Related]
5. Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines? Tomaszuk-Kazberuk A; Kozuch M; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Musial WJ Ren Fail; 2013; 35(2):235-42. PubMed ID: 23176538 [TBL] [Abstract][Full Text] [Related]
6. Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without β-blockers. Ogino K; Kato M; Furuse Y; Kinugasa Y; Kaetsu Y; Mizuta E; Sugihara S; Ishida K; Yanagihara K; Hisatome I; Shigemasa C Circ J; 2010 Nov; 74(11):2346-52. PubMed ID: 20827028 [TBL] [Abstract][Full Text] [Related]
8. The care for chronic heart failure by general practitioners. Results from a clinical audit in Italy. Cancian M; Battaggia A; Celebrano M; Del Zotti F; Novelletto BF; Michieli R; Saugo M; Pellizzari M; Toffanin R Eur J Gen Pract; 2013 Mar; 19(1):3-10. PubMed ID: 22998169 [TBL] [Abstract][Full Text] [Related]
9. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005]. Fabbri G; Gorini M; Maggioni AP; Di Lenarda A; G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354 [TBL] [Abstract][Full Text] [Related]
10. [Medical treatment of heart failure: an analysis of actual treatment practices in outpatients in Switzerland. The Swiss "IMPROVEMENT of HF" Group]. Muntwyler J; Follath F Schweiz Med Wochenschr; 2000 Aug; 130(34):1192-8. PubMed ID: 11013922 [TBL] [Abstract][Full Text] [Related]
11. Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failure. Hennekens CH; Kowalczykowski M; Hollar D J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):149-52. PubMed ID: 16891293 [TBL] [Abstract][Full Text] [Related]
12. Drug treatment for chronic systolic heart failure. Mörike K; Sindermann JR Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S170-2. PubMed ID: 20101534 [TBL] [Abstract][Full Text] [Related]
13. [Retrospective analysis of drug treatment on inpatients with chronic heart failure]. Ma JP; Wang L; Dang Q; Li YJ; Li XY; Zhang CZ; Li GP Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jan; 28(1):78-82. PubMed ID: 17575939 [TBL] [Abstract][Full Text] [Related]
14. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatment of chronic heart failure. Adorisio R; De Luca L; Rossi J; Gheorghiade M Heart Fail Rev; 2006 Jun; 11(2):109-23. PubMed ID: 16937030 [TBL] [Abstract][Full Text] [Related]
16. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice. Fishkind D; Paris BE; Aronow WS J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330 [TBL] [Abstract][Full Text] [Related]
17. A management programme for suspected heart failure in primary care in cooperation with specialists in cardiology. Mejhert M; Kahan T Eur J Gen Pract; 2015 Mar; 21(1):26-32. PubMed ID: 25342003 [TBL] [Abstract][Full Text] [Related]
18. Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial. Sakata Y; Shiba N; Takahashi J; Miyata S; Nochioka K; Miura M; Takada T; Saga C; Shinozaki T; Sugi M; Nakagawa M; Sekiguchi N; Komaru T; Kato A; Fukuchi M; Nozaki E; Hiramoto T; Inoue K; Goto T; Ohe M; Tamaki K; Ibayashi S; Ishide N; Maruyama Y; Tsuji I; Shimokawa H; ; Eur Heart J; 2015 Apr; 36(15):915-23. PubMed ID: 25637937 [TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project. Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552 [TBL] [Abstract][Full Text] [Related]
20. What primary care physicians know about diagnosis and treatment of chronic heart failure. Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A Kardiol Pol; 2005 Mar; 62(3):218-28. PubMed ID: 15830016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]